Provisional Consent to the Distribution of a New Medicine

Pursuant to section 23(1) of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the new medicine set out in the Schedule hereto:

Schedule

*Product:*	Sodium Chloride Injection
Active Ingredient:	Sodium chloride 9mg/mL
Dosage Form:	Solution for injection
New Zealand Sponsor:	Baxter Healthcare Limited
Manufacturer:	Baxter Healthcare (Shanghai) Co., Limited, Shanghai, China
Note: This consent is given subject to the following condition: The medicine may only be marketed or distributed when no other sodium chloride solution for injection medicine with consent under section 20 of the Medicines Act 1981 is available in the New Zealand market, or to meet PHARMAC supply obligations.
Note: This consent is valid for two years from the date of publication of this notice.

Dated this 9th day of September 2025.

MATTHEW SPENCER, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Provisional Consent to the Distribution of a New Medicine

Tags

Notice Number

Schedule